| 英文品名 |
pexelizumab |
| 名称来源 |
p-INNList-85,2001;r-INNList-47,2002; |
| 别 名 |
h5G1.1 scFv; h5G1.1 scFv (CDR) |
| 化学表述 |
immunoglobulin, anti-(human complement C5 α-chain) (human-mouse monoclonal 5G1.1-SC single chain) |
| CA登记号 |
219685-93-5 |
| 品种类别 |
免疫调节药>单克隆抗体类; immunomodulator; |
| 简介 |
上市（Alexion Pharmaceuticals, Inc.，美国）。Complement inhibitor used to reduce the impact of complement-mediated injuries sustained during cardiopulmonary bypass (humanized monoclonal antibody) |
|
